MétaCan
Menu
Retour à la cohorte
Enregistrement W4394800621 · doi:10.1016/s1474-4422(24)00083-8

MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study

2024· article· en· W4394800621 sur OpenAlexafffund
Rebecca R. Valentino, William J. Scotton, Shanu F. Roemer, Tammaryn Lashley, Michael G. Heckman, Maryam Shoai, Alejandro Martínez-Carrasco, Nicole Tamvaka, Ronald L. Walton, Matthew Baker, Hannah Macpherson, Raquel Real, Alexandra I. Soto‐Beasley, Kin Y. Mok, Tamás Révész, Elizabeth Christopher, Michael DeTure, William W. Seeley, Edward B. Lee, Matthew P. Frosch, Laura Molina‐Porcel, Tamar Gefen, Javier Redding‐Ochoa, Bernardino Ghetti, Andrew Robinson, Christopher Kobylecki, James B. Rowe, Thomas G. Beach, Andrew F. Teich, Julia Keith, István Bódi, Glenda M. Halliday, Marla Gearing, Thomas Arzberger, Christopher M. Morris, Charles L. White, Naguib Mechawar, Susana Boluda, Ian R. Mackenzie, Catriona McLean, Matthew D. Cykowski, Shih‐Hsiu J. Wang, Caroline Graff, Rashed M. Nagra, Gábor G. Kovács, Giorgio Giaccone, Manuela Neumann, Lee-Cyn Ang, Agostinho Carvalho, Huw R. Morris, Rosa Rademakers, John Hardy, Dennis W. Dickson, Jonathan D. Rohrer, Owen A. Ross, Thomas T. Warner, Zane Jaunmuktane, Bradley F. Boeve, Ranjan Duara, Neill R. Graff‐Radford, Keith A. Josephs, David S. Knopman, Shunsuke Koga, Melissa E. Murray, Kelly E. Lyons, Rajesh Pahwa, Ronald Petersen, Jennifer Whitwell, Lea T. Grinberg, Bruce L. Miller, Athena Schlereth, Salvatore Spina, Murray Grossman, David J. Irwin, EunRan Suh, John Q. Trojanowski, Vivianna M. Van Deerlin, David A. Wolk, Theresa R. Connors, Patrick M. Dooley, Derek H. Oakley, Ibán Aldecoa, Mircea Balasa, Ellen Gelpí, Sergi Borrego‐Écija, Jordi Gascón‐Bayarri, Raquel Sánchez‐Valle, Pilar Sanz-Cartagena, Gerard Piñol‐Ripoll, Eileen H. Bigio, Margaret E. Flanagan, Emily Rogalskı, Sandra Weıntraub, Julie A. Schneider, Lihua Peng, Xiongwei Zhu, Koping Chang, Juan C. Troncoso, Stefan Prokop, Kathy L. Newell, Matthew S. Jones, Anna Richardson, Federico Roncaroli, Julie S. Snowden, Kieren Allinson, Poonam Singh, Geidy E. Serrano, Xena Flowers, James E. Goldman, Allison C Heaps, Sandra Leskinen, Sandra E. Black, Mario Masellis, Andrew King, Safa Al‐Sarraj, Claire Troakes, John R. Hodges, Jillian J. Kril, John B. Kwok, Olivier Piguet, Sigrun Roeber, Johannes Attems, Alan Thomas, Bret M. Evers, Kevin F. Bieniek, Anne Sieben, Patrick Cras, Bart B De Vil, Thomas D. Bird, Rudolph J. Castellani, Ann Chaffee, Erin Franklin, Vahram Haroutunian, Max Jacobsen, Dirk Keene, Caitlin S. Latimer, Jeff Metcalf, Richard J. Perrin, Dushyant P. Purohit, Robert A. Rissman, Aimee Schantz, Jamie M. Walker, Peter Paul De Deyn, Charles Duyckaerts, Isabelle Le Ber, Danielle Seilhean, Sabrina Turbant-Leclere, John F. Ervin, Inger Nennesmo, James R. Riehl, Benedetta Nacmias, Elizabeth Finger, Cornelis Blauwendraat, Mike A. Nalls, Andrew Singleton, Dan Vitale, Cristina Cunha, Zbigniew K. Wszołek

Notice bibliographique

RevueThe Lancet Neurology · 2024
Typearticle
Langueen
DomaineMedicine
ThématiqueAlzheimer's disease research and treatments
Établissements canadiensLondon Health Sciences CentreUniversity of TorontoWestern UniversityOntario Brain InstituteUniversity of British ColumbiaMcGill UniversityToronto Rehabilitation InstituteDouglas Mental Health University InstituteOccupational Cancer Research CentreHealth Sciences CentreUniversity Health NetworkSunnybrook Health Science Centre
Organismes subventionnairesState of FloridaNational Institute on Deafness and Other Communication DisordersNational Institute on AgingFaculty of Medicine and Health, University of SydneyNederlands HerseninstituutNIHR Oxford Biomedical Research CentreSchulich School of Medicine and DentistryNational Health and Medical Research CouncilMedical Research CouncilAlzheimer's Disease Research Center, University of PittsburghNIHR Cambridge Biomedical Research CentreTau ConsortiumDirectorate for Biological SciencesRossy FoundationDrake FoundationSchulich School of Medicine and Dentistry, Western UniversityNational Institutes of HealthNationale Genossenschaft für die Lagerung radioaktiver AbfälleGoizueta Business School, Emory UniversityInstitute of Psychiatry, Psychology and Neuroscience, King’s College LondonVictorian Brain BankUK Dementia Research InstituteYulgilbar FoundationIrving Medical Center, Columbia UniversityCentre hospitalier universitaire Sainte-JustineSorbonne UniversitéUniversiteit AntwerpenCentre Hospitalier Universitaire de RennesCentre Hospitalier Régional Universitaire de MontpellierNational Institute of Neurological Disorders and StrokeArizona Biomedical Research CommissionDeutsches Zentrum für Neurodegenerative ErkrankungenMemphis Research ConsortiumBanco Bilbao Vizcaya ArgentariaChung Hua UniversityFondazione I.R.C.C.S. Istituto Neurologico Carlo BestaUniversità degli Studi di FirenzeKarolinska InstitutetUniversity of California, San FranciscoU.S. Department of Health and Human ServicesMayo ClinicUniversiteit GentNewcastle upon Tyne Hospitals NHS Foundation TrustAligning Science Across Parkinson’sUniversity of TorontoCurePSPEdmond J. Safra Philanthropic FoundationNew York State Department of HealthNewcastle UniversityFonds de Recherche du Québec - SantéSchool of Medicine, Emory UniversityUniversitair Ziekenhuis GentKing's College LondonUniversity of CambridgeParkinson's UKDepartment of Health and Social CareAlzheimer SocietyNational Institute for Health and Care ResearchNederlandse HersenbankNIHR Newcastle Biomedical Research CentreEvelyn TrustAlzheimer’s Research UKLewy Body Dementia AssociationCanadian Institutes of Health ResearchAlzheimer's SocietyFightMNDPSP AssociationMayo Foundation for Medical Education and ResearchNorthwestern UniversitySunnybrook Research InstituteWellcome TrustKlinisch Chemisch LaboratoriumArizona Department of Health ServicesKing's College Hospital NHS Foundation TrustRainwater Charitable FoundationFondation Brain CanadaLondon Health Sciences CentreMcGill UniversityDemensförbundetParkinson’s VictoriaMichael J. Fox Foundation for Parkinson's ResearchEmory UniversityCambridge University HospitalsPCB SolutionsUniversity of PennsylvaniaCanada First Research Excellence FundLittle Family FoundationNational Institute on Handicapped ResearchFundación BBVAUniversidade do MinhoBrain Research UKU.S. Department of Defense
Mots-clésProgressive supranuclear palsyCorticobasal degenerationHaplotypeTauopathyTau proteinFrontotemporal dementiaDiseaseMedicineDementiaPick's diseaseGeneticsAlzheimer's diseasePathologyBiologyGenotypeNeurodegenerationGene

Résumé

récupéré en direct d'OpenAlex

BACKGROUND: Pick's disease is a rare and predominantly sporadic form of frontotemporal dementia that is classified as a primary tauopathy. Pick's disease is pathologically defined by the presence in the frontal and temporal lobes of Pick bodies, composed of hyperphosphorylated, three-repeat tau protein, encoded by the MAPT gene. MAPT has two distinct haplotypes, H1 and H2; the MAPT H1 haplotype is the major genetic risk factor for four-repeat tauopathies (eg, progressive supranuclear palsy and corticobasal degeneration), and the MAPT H2 haplotype is protective for these disorders. The primary aim of this study was to evaluate the association of MAPT H2 with Pick's disease risk, age at onset, and disease duration. METHODS: In this genetic association study, we used data from the Pick's disease International Consortium, which we established to enable collection of data from individuals with pathologically confirmed Pick's disease worldwide. For this analysis, we collected brain samples from individuals with pathologically confirmed Pick's disease from 35 sites (brainbanks and hospitals) in North America, Europe, and Australia between Jan 1, 2020, and Jan 31, 2023. Neurologically healthy controls were recruited from the Mayo Clinic (FL, USA, or MN, USA between March 1, 1998, and Sept 1, 2019). For the primary analysis, individuals were directly genotyped for the MAPT H1-H2 haplotype-defining variant rs8070723. In a secondary analysis, we genotyped and constructed the six-variant-defined (rs1467967-rs242557-rs3785883-rs2471738-rs8070723-rs7521) MAPT H1 subhaplotypes. Associations of MAPT variants and MAPT haplotypes with Pick's disease risk, age at onset, and disease duration were examined using logistic and linear regression models; odds ratios (ORs) and β coefficients were estimated and correspond to each additional minor allele or each additional copy of the given haplotype. FINDINGS: We obtained brain samples from 338 people with pathologically confirmed Pick's disease (205 [61%] male and 133 [39%] female; 338 [100%] White) and 1312 neurologically healthy controls (611 [47%] male and 701 [53%] female; 1312 [100%] White). The MAPT H2 haplotype was associated with increased risk of Pick's disease compared with the H1 haplotype (OR 1·35 [95% CI 1·12 to 1·64], p=0·0021). MAPT H2 was not associated with age at onset (β -0·54 [95% CI -1·94 to 0·87], p=0·45) or disease duration (β 0·05 [-0·06 to 0·16], p=0·35). Although not significant after correcting for multiple testing, associations were observed at p less than 0·05: with risk of Pick's disease for the H1f subhaplotype (OR 0·11 [0·01 to 0·99], p=0·049); with age at onset for H1b (β 2·66 [0·63 to 4·70], p=0·011), H1i (β -3·66 [-6·83 to -0·48], p=0·025), and H1u (β -5·25 [-10·42 to -0·07], p=0·048); and with disease duration for H1x (β -0·57 [-1·07 to -0·07], p=0·026). INTERPRETATION: The Pick's disease International Consortium provides an opportunity to do large studies to enhance our understanding of the pathobiology of Pick's disease. This study shows that, in contrast to the decreased risk of four-repeat tauopathies, the MAPT H2 haplotype is associated with an increased risk of Pick's disease in people of European ancestry. This finding could inform development of isoform-related therapeutics for tauopathies. FUNDING: Wellcome Trust, Rotha Abraham Trust, Brain Research UK, the Dolby Fund, Dementia Research Institute (Medical Research Council), US National Institutes of Health, and the Mayo Clinic Foundation.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,021
Score d'incertitude au seuil0,230

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0000,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0000,000
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,027
Tête enseignante GPT0,325
Écart entre enseignants0,298 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations23
Publié2024
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revueThe Lancet NeurologyMême sujetAlzheimer's disease research and treatmentsTravaux en français237 207